|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-11-10
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Breast cancer concern is a major reason for the recent marked reduction in use of postmenopausal hormone therapy, although equally effective means of controlling menopausal symptoms are lacking. Single nucleotide polymorphisms (SNP) in the fibroblast growth factor receptor 2 (FGFR2) gene are substantially associated with postmenopausal breast cancer risk and could influence hormone therapy effects.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/24152,
http://linkedlifedata.com/resource/pubmed/grant/32100-2,
http://linkedlifedata.com/resource/pubmed/grant/32105-6,
http://linkedlifedata.com/resource/pubmed/grant/32108-9,
http://linkedlifedata.com/resource/pubmed/grant/32111-13,
http://linkedlifedata.com/resource/pubmed/grant/32115,
http://linkedlifedata.com/resource/pubmed/grant/32118-19,
http://linkedlifedata.com/resource/pubmed/grant/32122,
http://linkedlifedata.com/resource/pubmed/grant/42107-26,
http://linkedlifedata.com/resource/pubmed/grant/42129-32,
http://linkedlifedata.com/resource/pubmed/grant/44221,
http://linkedlifedata.com/resource/pubmed/grant/CA53996,
http://linkedlifedata.com/resource/pubmed/grant/HHSN268200764314C,
http://linkedlifedata.com/resource/pubmed/grant/N01 WH022110-024,
http://linkedlifedata.com/resource/pubmed/grant/N01WH22110,
http://linkedlifedata.com/resource/pubmed/grant/P01 CA053996-32
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1538-7755
|
|
pubmed:author |
pubmed-author:BallingerDennis GDG,
pubmed-author:BeilharzEricaE,
pubmed-author:CaanBetteB,
pubmed-author:ChlebowskiRowan TRT,
pubmed-author:CoxDavid RDR,
pubmed-author:HindsDavid ADA,
pubmed-author:HuangYingY,
pubmed-author:PetersUlrikeU,
pubmed-author:PettingerMaryM,
pubmed-author:PrenticeRoss LRL,
pubmed-author:RossouwJacques EJE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3079-85
|
|
pubmed:dateRevised |
2011-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:19861516-Aged,
pubmed-meshheading:19861516-Breast Neoplasms,
pubmed-meshheading:19861516-Case-Control Studies,
pubmed-meshheading:19861516-Cohort Studies,
pubmed-meshheading:19861516-Estrogen Replacement Therapy,
pubmed-meshheading:19861516-Estrogens,
pubmed-meshheading:19861516-Female,
pubmed-meshheading:19861516-Genotype,
pubmed-meshheading:19861516-Humans,
pubmed-meshheading:19861516-Introns,
pubmed-meshheading:19861516-Linkage Disequilibrium,
pubmed-meshheading:19861516-Middle Aged,
pubmed-meshheading:19861516-Neoplasm Invasiveness,
pubmed-meshheading:19861516-Neoplasm Staging,
pubmed-meshheading:19861516-Polymorphism, Single Nucleotide,
pubmed-meshheading:19861516-Postmenopause,
pubmed-meshheading:19861516-Progestins,
pubmed-meshheading:19861516-Prognosis,
pubmed-meshheading:19861516-Receptor, Fibroblast Growth Factor, Type 2,
pubmed-meshheading:19861516-Risk Factors,
pubmed-meshheading:19861516-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.
|
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. rprentic@fhcrc.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|
